Valuation of Selected Company Under Risk Terms
Loading...
Downloads
2
Date issued
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Vysoká škola báňská – Technická univerzita Ostrava
Location
Signature
Abstract
Jiangsu Hengrui Pharmaceuticals is a pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs. It is the largest research and production base of anticancer drugs of China. From generic to innovative, the study of the company helps us to understand development of China’s pharmaceutical industry.
Based on this background, the thesis will estimate the probability distribution of Hengrui’s market value at the end of 2020 by applying discounted cash flow method
Description
Subject(s)
Pharmaceutical Market； Valuation